Wacker, XL-protein sign cooperation agreement to produce biopharmaceuticals
07:54 AM | November 5, 2012 | Deepti Ramesh
Wacker says that its Wacker Biotech (Jena, Germany) subsidiary and XL-protein (Freising, Germany), a privately owned biopharmaceutical company, have signed an agreement to collaborate more intensely...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.